Pharmaceutical Technology-10-02-2012

Issue PDF
Pharmaceutical Technology

October 02, 2012

Combination Drugs - Adding Up the Opportunities in Solid Dosage

Pharmaceutical Technology

Managing risk in biopharmaceutical operations is of utmost importance for patient protection.

Pharmaceutical Technology
Special Features

October 02, 2012

PharmTech spoke with industry experts about the challenges of implementing disposable chromatography systems.

Pharmaceutical Technology

New European Pharmacopoeia chapter aims to resolve problems with applying the harmonized UDU test to large sample sizes.

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

Pharmaceutical Technology
From The Editor

October 02, 2012

Will the next US President support the backbone of our industry?

Pharmaceutical Technology

The authors describe how traditional approaches to analytical method and validation may benefit from alignment with quality-by-design concepts.

Pharmaceutical Technology
Special Features

October 02, 2012

This article provides a comparison of Rx-360, EXCiPACT and IPEA, available to pharmaceutical manufacturers for the purpose of auditing excipient suppliers and ensuring drug efficacy and patient safety.

Pharma Ingredients
Pharmaceutical Technology

October 02, 2012

Recent research on elucidating the structure and sequence of proteins involves examining the effect of microgravity on protein crystallization and a computational model for protein elucidation.

Pharmaceutical Technology
Analytical & Bioanalytical Solutions

October 02, 2012

Potency is a required measurement to determine the amount of active ingredient contained in a preclinical dose formulation. Assessing potency ensures that the test system receives the appropriate amount of active ingredient based on predetermined specifications.

Pharmaceutical Technology
In the Field

October 02, 2012

Foreign firms struggle against stricter patent laws, but all is not lost.

Pharmaceutical Technology
Statistical Solutions

October 02, 2012

Real-time experimentation may offer continuous process improvement.

Pharmaceutical Technology

Today's pharmaceutical companies are striving to reduce costs and maximize efficiencies, and must make decisions on the best way to deploy their limited resources.

Agent-in Place
Pharmaceutical Technology

October 02, 2012

Only the strong survive when it comes to pharmaceutical packaging and shipping.

Pharmaceutical Technology
Peer-Reviewed Research

October 02, 2012

The authors examine the use of various grades of direct-compression mannitol in direct-compression tableting process to evaluate the content uniformity of micronized APIs and excipients in a solid-dosage formulation.

Pharmaceutical Technology

A Q&A with James Ingebrand, Vice President and General Manager of 3M Drug Delivery Systems Division, on recent industry trends.

Pharmaceutical Technology
Pharma Ingredients

October 02, 2012

Particle-engineering technologies, such as crystal design for crystallization and producting cocrystals, particle-size reduction, and amorphous solid dispersions, help to optimize delivery of a drug.

Pharmaceutical Technology
In the Spotlight

October 02, 2012

New product reviews for October 2012, featuring analytical equipment.

Pharmaceutical Technology
BioForum

October 02, 2012

The long-awaited patent cliff that has loomed in the pharmaceutical industry for years has arrived in earnest in 2012, with more than $40 billion in 2011 brand sales facing loss of exclusivity.

Pharmaceutical Technology

This study examines the effect and interaction of variations in hypromellose physicochemical properties.

Pharmaceutical Technology

Working together affords many unseen opportunities for pharmaceutical innovation.

Pharmaceutical Technology
Special Report

October 02, 2012

Fixed-dose combination drug therapies give rise to innovation in solid-dosage formulations and manufacturing.

Pharmaceutical Technology
Regulatory Watch

October 02, 2012

The promise of the Generic Drug User Fee Amendments of 2012 is to end multiyear reviews of new generic drugs and the ever-growing queue of pending applications.

Pharmaceutical Technology

Recent news stories have reported that FDA scientists have been suspected of leaking confidential, commercial, and trade secret information to the media.

Pharmaceutical Technology
Outsourcing Outlook

October 02, 2012

Measuring the size of the market for contract manufacturing services requires a careful hand.

In the Field
Pharmaceutical Technology

October 02, 2012

Q&A with David Elder and Richard Wright of Strategic Compliance Consulting, PAREXEL International. Both Elder and Wright formerly served with FDA.